维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Garland LL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase I pharmacokinetic study of H MN-214, a novel oral stilbene derivative with Polo-like kinase-1-interacting properties, in patients with advanced solid tumors 显示文摘	Garland LL Tayor C Pilkington DL	2006	Clin Cancer Res2006，12，7：	1
2	Re- lationship of hemoglobin levels to fatigue and cognitive func- tioning among cancer patients receiving chemotherapy 显示文摘	JACOBSEN PB GARLAND LL BOOTH-JONES M et ai	2004	J Pain Symptom Manage2004，28，1：	1
3	Relationship of hemo-globin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy显示文摘	Jacobsen PB Garland LL Booth-Jones M	2004	J Pain Symptom Manage2004，28，1：	1
4	Phase Ⅱ study of cediranib in patients with malignant pleural mesothelioma:SWOG S0509显示文摘	Garland LL Chansky K Wozniak AJ		0，，11：	1
5	Phase Ⅱ study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study 显示文摘	Garland LL Rankin C Gandara DR	2007	J Clin Oncol2007，25，17：	1
6	Phase Ⅰ study of BMS-599626,an oral pan-HER tyrosine kinase inhibitor,in patients with advanced solid tumors显示文摘	Garland LL Pegram M Song S	2005	J Clin Oncol2005，2005，23：	1
7	Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy显示文摘	Jacobsen PB Garland LL Booth - Jones M	2004	J Pain Symptom Manage2004，28，1：	1
8	Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy 显示文摘	Jacobsen PB Garland LL Booth-Jones M	2004	J Pain Symptom Manage2004，28，1：	1
9	Phase II study of erlotinib in patients with malignant pleural mesothelioma:a Southwest Oncology Group Study显示文摘	Garland LL Randkin C Gandara DR	2007	J Clin Oncol2007，25，17：	1
10	Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study显示文摘	GARLAND LL RANKIN C GANDARA DR	2007	J Clin Oncol2007，25，17：	1
11	Phase II study of cediranib in patients with malignant pleural mesothelioma:SWOG S0509显示文摘	Garland LL Chansky K Wozniak AJ	2011	J Thorac Oncol2011，6，11：	1
12	A phase I clinical and pharrnacokinetic study of ora1 CI-1033 in combination with docetaxel in patients with advanced solid tumors显示文摘	Garland LL Hidalgo M Mendelson DS	2006	Clin Cancer Res2006，12，141：	1
13	Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy显示文摘	Jacobsen PB Garland LL Booth-Jones M	2004	J Pain Symptom Manage2004，28，1：	1
14	SWOG S0722:phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma( MPM ) 显示文摘	OU SH MOON J GARLAND LL	2015	J Thorac Oncol2015，10，2：	1
15	Phase II study of erlotinib in patients with malignant pleural mesothelioma:a Southwest Oncology Group Study 显示文摘	Garland LL Rankin C Gandara DR	2007	J Clin Oncol2007，25，17：	1
16	Phase Ⅱ study of erlotinib in patients with malignant pleural mesothelioma:a Southwest Oncology Group Study显示文摘	Garland LL Randkin C Gandara DR	2007	J Clin Oncol2007，25，17：	1
17	phase II study of erlotinib in patients with malignant pleural mesothelioma:a Surthwest Oncology Group study显示文摘	Garland LL Randkin C Gandana DR	2007	J Clin Oncol2007，25，：	1
18	A phase Ⅰ clinical and pharmacokinetic study of oral CI - 1033 in combination with docetaxel in patients with advanced solid tumors显示文摘	Garland LL Hidalgo M Mendelson DS	2006	Clin Canc Res2006，12，14：	1
19	Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy显示文摘	Jacobsen PB Garland LL Booth-Jones M	2004	J Pain Symptom Manage2004，28，1：	1
20	Vitamin D supplementdoses and serum 25 -hydroxyvitamin D in the range associated withcancer prevention显示文摘	Garland CF French CB Baggerly LL	2011	Anticancer Res2011，31，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示